What Software Teams Should Understand About CSV in Pharma
Software used in pharmaceutical GxP processes has a different context from an ordinary business application. Its intended use, potential impact and applicable requirements influence the validation evidence and controls that an organisation needs.
For developers, QA engineers and implementation teams, several principles are worth understanding.
Requirements Must Be Traceable
Requirements should connect to risk assessments, test cases, test results and deviations. This relationship helps reviewers understand whether the intended functions were assessed and how exceptions were resolved.
Testing Should Reflect Risk
The depth of testing should be justified by intended use and risk. Teams should document why particular functions require specific testing and retain evidence supporting their decisions.
Auditability Is Part of the Design
Access controls, audit trails, approval records and electronic signatures need to be evaluated in the context of the applicable requirements. Simply adding an audit-log feature does not prove that the complete system is suitable for regulated use.
Changes Need an Assessment Process
New releases, configuration changes and updates can affect system behaviour. Teams should establish a process for assessing impact, deciding on testing and retaining the resulting evidence.
Tools Do Not Replace Accountability
A CSV platform may organise requirements, testing, documentation and approvals. However, the regulated organisation remains responsible for ensuring the system is suitable for its intended use and operated under appropriate controls.
If you work on software implementation or quality engineering in pharma, this broader guide to https://incepbio.com/blog/computer-system-validation-software/ covers selection criteria, traceability and supplier evaluation.
The most useful validation workflow is one that connects technical evidence to clear requirements, risk decisions and accountable review.
Top comments (0)